Clinical Trial Update: Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating cladribine in combination with CAG for efficacy and safety in newly diagnosed unfit patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CAG
• Cladribine (cladribine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Acute Myeloid Leukemia, Elderly Patients | Phase 2 | Status: UNKNOWN